Exchange Traded Concepts Price, Forecast, Insider, Ratings, Fundamentals & Signals

Business combination transaction with first light acquisition group, a special purpose acquisition company, completed on september 12, 2023

Business combination transaction with calidi biotherapeutics anticipated to be completed on september 12, 2023 gross proceeds made available to calidi biotherapeutics from transaction will total approximately $28 million, including funds held in first light acquisition group's trust account before deducting transaction expenses and debt repayments in addition, calidi secured a forward purchase agreement for up to $10 million with a consortium including meteora capital llc, great point capital llc, and funicular funds, lp listed company to be named calidi biotherapeutics, inc. common stock and warrants approved for listing on the new york stock exchange american under the ticker symbols “cldi” and “cldi ws,” respectively; expected to begin trading on september 13, 2023 new york, sept...

New york, aug. 22, 2023 (globe newswire) -- first light acquisition group, inc. (nyse: flag) (“flag”) today announced that it convened and then adjourned, without conducting any other business, its virtual special meeting of stockholders to august 24, 2023 at 10:30 a.m., eastern time (the “special meeting”). the adjourned special meeting will be held via the same live webcast at https://www.cstproxy.com/firstlightacquisition/2023.

Reston, va, aug. 16, 2023 (globe newswire) -- irst light acquisition group, inc. (“flag”) (nyse american: flag), a special purpose acquisition company, reminds flag stockholders that the flag board of directors unanimously recommends that flag stockholders vote for the proposed business combination (the “business combination”) with calidi biotherapeutics, inc. (“calidi”), a clinical-stage biotechnology company that is pioneering the development of allogeneic cell-based delivery of oncolytic viruses.

Reston, va., aug. 07, 2023 (globe newswire) -- first light acquisition group, inc. (“flag”) (nyse american: flag), a special purpose acquisition company, today announced that the u.s. securities and exchange commission (the “sec”) has declared effective flag's registration statement on form s-4 (as amended to the date hereof, the “registration statement”). the registration statement includes a proxy statement/prospectus for the special meeting of the stockholders of flag in connection with its proposed combination with calidi biotherapeutics, inc. (“calidi”), a clinical-stage biotechnology company that is pioneering the development of allogeneic cell-based delivery of oncolytic viruses.

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) -- First Light Acquisition Group, Inc. (the “Company”), a blank check company formed for the purpose of entering into a combination with one or more businesses or entities, announced today the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the full exercise by the underwriter of its over-allotment option, at a price of $10.00 per unit. The units have been listed on the New York Stock Exchange (“NYSE”) and have started trading under the ticker symbol “FLAGU.” Each unit issued in the offering consists of one share of the Company's Class A common stock and one-half of one redeemable warrant of the Company...